# Sublingual Micronized NMN (1g) + TMG (500mg) - Clinical Longevity Review & Consensus Audit

> **Consensus Verdict**: This clearance strictly requires NAM to be heavily methylated into N1-methylnicotinamide (MeNAM) by the enzyme nicotinamide N-methyltransferase (NNMT), a taxing process that consumes vast quantities of the body's endogenous methyl donors (primarily S-adenosylmethionine, or SAMe)44. Chronic, high-dose NAD+ precursor supplementation without a methyl donor can therefore severely deplete the systemic methyl pool. This methyl depletion leads to impaired gene methylation, disrupted neurotransmitter synthesis, and a dangerous, silent accumulation of homocysteine—an inflammatory amino acid highly correlated with lethal cardiovascular disease44. Co-supplementing with TMG provides a robust, exogenous source of methyl groups, effectively resupplying the biochemical "fuel" required for NNMT activity, ensuring the safe and rapid excretion of NAM metabolic waste, driving the re-methylation of toxic homocysteine back into safe methionine, and allowing for sustained, high-dose NMN therapy without inducing any metabolic toxicity44.

## 1. Executive Summary & Scores
- **Longevity Evidence Score**: **88/100**
- **Evidence Quality Tier**: **silver**
- **Human Clinical Evidence Strength**: 82/100
- **Primary Longevity Classification**: supplements
- **Safety Margin Score**: 92/100 (Higher is safer)
- **Time Burden**: ~15 minutes/day
- **Estimated Monthly Cost**: moderate
- **Adherence Friction**: 3/10 (Lower is easier to sustain)

---

## 2. Biological Mechanisms of Action
This clearance strictly requires NAM to be heavily methylated into N1-methylnicotinamide (MeNAM) by the enzyme nicotinamide N-methyltransferase (NNMT), a taxing process that consumes vast quantities of the body's endogenous methyl donors (primarily S-adenosylmethionine, or SAMe)44. Chronic, high-dose NAD+ precursor supplementation without a methyl donor can therefore severely deplete the systemic methyl pool. This methyl depletion leads to impaired gene methylation, disrupted neurotransmitter synthesis, and a dangerous, silent accumulation of homocysteine—an inflammatory amino acid highly correlated with lethal cardiovascular disease44. Co-supplementing with TMG provides a robust, exogenous source of methyl groups, effectively resupplying the biochemical "fuel" required for NNMT activity, ensuring the safe and rapid excretion of NAM metabolic waste, driving the re-methylation of toxic homocysteine back into safe methionine, and allowing for sustained, high-dose NMN therapy without inducing any metabolic toxicity44.

---

## 3. Canonical Longevity Vector Impacts (The 8 Longevity Pillars)
- **Cellular Longevity & Autophagy**: **82/100** [Rank #57 of 131 in Cellular] - Effect: Maintains genomic stability, telomeric integrity, extracellular collagen matrix, and mitochondrial proteostasis
    - Mechanism: Activates nuclear transcription factors (SIRT1/RAR), photobiomodulates cytochrome c oxidase, or enhances DNA strand break repair.

---

## 4. Practical Protocol & Administration Guidelines
- **Standard Clinical Dosage**: 1,000mg Sublingual NMN + 500mg Trimethylglycine (TMG)
- **Recommended Timing**: Upon waking (07:00 AM) with water
- **Administration Type**: supplement
- **Recommended Biomarkers to Monitor**: energy, endurance, focus, cellular_longevity

---

## 5. Safety, Contraindications & Drug Interactions
- **Contraindications**: None reported in standard human trials with recommended doses.
- **Safety Profile**: low_risk - Well tolerated within physiological ranges.

---

## 6. Peer-Reviewed Human Clinical Trials & Key PMIDs
1. **Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: A randomized, double-blind study** [PMID: 34238308]
   - Link: https://pubmed.ncbi.nlm.nih.gov/34238308/
2. **Oral administration of NMN improves cerebral blood flow and attenuates daytime executive fatigue** [PMID: 35732835]
   - Link: https://pubmed.ncbi.nlm.nih.gov/35732835/
3. **The efficacy and safety of beta-nicotinamide mononucleotide (NMN) in healthy adults: A randomized, multicenter, double-blind clinical trial** [PMID: 36484374]
   - Link: https://pubmed.ncbi.nlm.nih.gov/36484374/
4. **Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women** [PMID: 33888596]
   - Link: https://pubmed.ncbi.nlm.nih.gov/33888596/
5. **NAD+ Intermediates and Longevity Therapeutics** [PMID: 30894380]
   - Link: https://pubmed.ncbi.nlm.nih.gov/30894380/

---

## 7. Canonical Citation & Web Verification
- **Official Web Review**: [Sublingual Micronized NMN (1g) + TMG (500mg) on LongevityReviews](https://longevityreviews.org/modalities/sinclair_nmn_tmg)
- **Last Evidence Calibration**: 2026-08-08
- **Review Policy**: 0% sponsored placements, independent peer-reviewed consensus.